| Republic of Korea | Turkey | Austria | |
| Removal of liver cancer | from $11,550 | from $10,800 | from $40,000 |
| Radiofrequency ablation of the liver | from $6,200 | from $3,500 | from $12,000 |
| Liver resection | from $15,800 | from $6,000 | from $35,000 |
| Chemoembolization of the liver | from $4,800 | from $7,500 | from $16,000 |
| Chemotherapy for liver cancer | from $3,000 | from $1,800 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Metastases in the liver treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Metastases in the liver treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Metastases in the liver treatment journey.
Dr. Dong Wook Choi is a professor and hepato-biliary pancreatic surgery specialist at Samsung Medical Center. He completed a fellowship at the University of Pittsburgh in the USA. Dr. Choi also received training at Kyoto University College of Medicine in Japan. He focuses on complex oncology cases, specifically pancreatic cancer and liver conditions.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
Latest treatments for liver metastases in South Korea include living donor liver transplantation, robotic resections, and transarterial radioembolization (TARE). JCI-accredited centers in Seoul utilize multidisciplinary tumor boards. These teams combine targeted immunotherapy with locoregional techniques like radiofrequency ablation to maximize survival rates.
Bookimed Expert Insight: While many countries maintain strict liver transplant criteria, Asan Medical Center reports a 90% success rate with organ transplants. This level of expertise attracts international patients from the USA and UAE. Data shows these top-tier centers manage massive volumes, with Severance Hospital seeing 1.6 million outpatients annually. This high frequency translates to deeper surgical experience for complex metastatic cases.
Patient Consensus: Patients emphasize finding a high-volume center where a multidisciplinary tumor board can determine if lesions are resectable. Many note that local surgeons often use pre-treatment to shrink tumors before attempting removal.
South Korea bietet fortschrittliche nicht-chirurgische Behandlungen für Lebermetastasen an. Patienten erhalten Zugang zu Radiofrequenzablation (RFA), transarterieller Chemoembolisation (TACE) und innovativer Schwerionentherapie. Diese minimalinvasiven Methoden zerstören Tumorgewebe gezielt ohne Skalpell. Onkologische Zentren mit JCI-Akkreditierung nutzen diese Verfahren bei inoperablen Befunden.
Bookimed Expert Insight: Ein signifikanter Trend in Seoul ist die digitale Integration der Patientenpfade. Das Seoul National University Hospital und das Samsung Medical Center behandeln jährlich über 2 Millionen Patienten. Diese enorme Fallzahl ermöglicht es den Onkologen, selbst kleinste Metastasen mittels KI-gestützter Bildgebung für die Ablation präzise zu lokalisieren. Für Patienten bedeutet diese Erfahrung oft eine höhere Erfolgsrate bei technisch schwierigen, nicht-chirurgischen Eingriffen.
Patient Consensus: Patienten betonen oft, dass eine Operation bei multiplen Metastasen nicht immer die beste Lösung ist. Sie empfehlen dringend eine multidisziplinäre Zweitmeinung, um lokale Therapien wie die Ablation mit systemischer Onkologie sinnvoll zu kombinieren.
Top Korean hospitals for liver metastases include Asan Medical Center, Samsung Medical Center, and Seoul National University Hospital. These centers feature specialized hepatobiliary departments. They utilize advanced image-guided radiation and robotic surgery. Most facilities hold JCI or KOIHA accreditations for oncology safety.
Bookimed Expert Insight: Patient volume often signals surgical expertise in Seoul. Asan Medical Center performs over 65,500 operations annually. This high frequency helps surgeons maintain precision in complex liver resections. For digital-first care, Seoul National University Bundang Hospital led as the first fully digitalized facility.
Patient Consensus: Patients note that major Seoul centers prioritize multidisciplinary care. They recommend bringing original pathology slides to speed up the treatment review process.
South Korea provides superior liver-metastases treatment through world-class surgical expertise and specialized multi-modal care. High-volume centers report 5-year survival rates exceeding 90% for specific liver pathologies. Advanced facilities utilize robotic surgery, Da Vinci systems, and chemoembolization to manage complex secondary tumors efficiently.
Bookimed Expert Insight: While many countries offer liver surgery, South Korea stands out for extreme specialization in high-volume oncology. Asan Medical Center performs over 65,000 operations annually, often handling cases others might refuse. This concentration of complex procedures means Korean surgeons refine their techniques much faster than those in lower-volume systems.
Patient Consensus: Patients value the speed of the Korean system, noting that imaging and treatment often begin much faster than in Western countries. International visitors also appreciate the smooth coordination provided by dedicated English-speaking departments in Seoul.
Surgery for liver metastases is possible in South Korea, particularly for patients with colorectal cancer. Specialists perform liver resection when tumours are confined or limited. Major Seoul centres use multi-step treatments. They combine surgery with chemotherapy or radiofrequency ablation to clear metastatic disease.
Bookimed Expert Insight: South Korea's highest-volume hospitals, such as Asan Medical Center, report a 98% liver transplant success rate. This level of hepatobiliary expertise translates directly to complex metastatic surgery. Patients often find that Seoul university hospitals achieve higher anus-preservation rates in colon-to-liver cases than many Western institutions.
Patient Consensus: Patients note that major Seoul hospitals require extensive disease verification before planning surgery. Experience shows that resection is most successful when the disease responds well to chemotherapy first.
South Korean hospitals treat liver metastasis. They use surgical resection, proton beam therapy, and targeted systemic treatments. Major centres like Samsung Medical Center and Asan Medical Center employ multidisciplinary teams. They specialise in laparoscopic liver surgery and interventional techniques. These techniques are for complex colorectal and gastric cancer cases.
Bookimed Expert Insight: South Korea leads in surgical volume. Seoul National University Hospital performs over 1,000 liver transplants. This high volume translates to exceptional technical proficiency in complex liver resections. These resections often involve major blood vessels. Patients with advanced cases benefit from this experience. Surgeons here often successfully resect tumours that other centres might deem inoperable.
Patient Consensus: Patients note that major Seoul hospitals provide fast-tracked consultations and diagnostic tests for international arrivals. They emphasise that these centres are busy. However, the multidisciplinary approach means every specialist reviews the case together.
South Korean clinics use immunotherapy and targeted therapy as primary treatments for liver metastases. Specialists often combine these systemic therapies with local procedures like TACE. Major centres in Seoul hold JCI and ISO accreditations. This means patients receive care that meets strict international safety standards.
Bookimed Expert Insight: South Korean oncology stands out because major hospitals report high success rates. Asan Medical Center, for instance, reports a 98% liver transplant success rate. This hepatobiliary expertise means their medical teams are skilled at managing complex liver function. They apply this during intensive immunotherapy cycles. Patients benefit from this deep surgical and physiological knowledge. They gain from it even when only receiving drug-based treatments.
Patient Consensus: Patients note that Korean medical teams prioritise mutation testing. This helps select the most effective drug combinations. They appreciate the focus on managing fatigue while tumours shrink. However, they emphasise the need to monitor liver function closely during treatment in South Korea.
TACE and radioembolisation are minimally invasive procedures that target liver tumours through their blood supply. South Korean specialists use TACE to trap chemotherapy inside tumours. Radioembolisation (TARE) delivers high-dose radiation via Yttrium-90 beads. These are preferred for metastatic cases where surgery is not possible.
Bookimed Expert Insight: South Korea's leadership in liver treatment stems from massive surgical volumes. Severance Hospital alone handles 40,000 operations annually. This high frequency allows interventional radiologists to refine superselective techniques. Patients often find that combining TACE with regional therapies yields better tumour shrinkage than single-modality treatment. Samsung Medical Center, for example, provides such combined therapies.
Patient Consensus: Patients note that while the procedures can cause temporary discomfort, they often lead to reduced cancer markers and improved wellbeing. Those treated in Seoul suggest discussing pain management upfront. They also confirm these therapies work best when the disease is primarily confined to the liver.
South Korean clinics provide world-leading care for colorectal liver metastases. They report 5-year survival rates that exceed those in Australia and the United States. Specialist centres like Samsung Medical Center use proton beam therapy and robotic liver resection. These methods treat complex secondary tumours.
Bookimed Expert Insight: Clinical data shows a shift towards minimally invasive techniques in Seoul. Seoul National University Bundang Hospital performs 90% of certain oncology surgeries laparoscopically. This includes world-first paediatric liver resections. For Australian patients, this technical mastery means two things: shorter hospital stays and faster recovery. These are significant improvements over traditional open surgery.
Patient Consensus: Patients often mention the incredible efficiency of the diagnostic process in Seoul. They appreciate getting PET-CT scans and specialist consultations within days rather than weeks. Many note the calm, hotel-like environment of centres like Samsung Medical Center. This helps reduce treatment stress.
Patients typically stay 1 to 2 weeks for minimally invasive liver metastases treatments. These include chemoembolisation or ablation. Major surgeries require a longer stay of 1 to 2 months. These include liver resection or transplantation. JCI-accredited Seoul centres often conduct diagnostic assessments during the first week.
Bookimed Expert Insight: Korea University Anam Hospital offers same-day consultations and tests for new cancer patients. This protocol can significantly reduce the usual 1-week waiting period for initial assessments. Australian patients should look for clinics with this "One-Stop" service. It helps cut down on total travel time and accommodation costs in Seoul.
Patient Consensus: Patients note that Korean medical teams often repeat all pathology and diagnostic scans upon arrival. Bringing translated records helps. Even so, most treat it as a multi-week commitment, not a quick medical holiday.